ACM
IMNM icon

Aquatic Capital Management’s Immunome IMNM Stock Holding History

Aquatic Capital Management’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-31,323
Closed -$673K – 1591
2025
Q4 		$673K Buy
+31,323
New +$550K 0.02% 657
2025
Q1 		– Sell
-8,935
Closed -$94.9K – 1432
2024
Q4 		$94.9K Buy
+8,935
New +$108K ﹤0.01% 1078
2024
Q3 		– Sell
-30,400
Closed -$368K – 1337
2024
Q2 		$368K Buy
+30,400
New +$476K 0.01% 609

Other funds holding IMNM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return

Aquatic Capital Management's IMNM Position: Q1 2026 in Review

Aquatic Capital Management sold out of Immunome (IMNM) in Q1 2026, closing a stake of 31,323 shares — an estimated $673K sold.

Aquatic Capital Management first reported a position in IMNM in Q2 2024 and held it in 3 quarters. The position peaked at $673K in Q4 2025. 200 funds tracked by Wall St. Rank hold IMNM as of Q1 2026.

  • Aquatic Capital Management reported no remaining Immunome position as of Q1 2026 after selling out during the quarter.
  • Aquatic Capital Management sold 31,323 Immunome shares in Q1 2026, an estimated $673K.
  • Aquatic Capital Management first reported a position in Immunome in Q2 2024 and held it in 3 quarters.
  • Aquatic Capital Management's Immunome position peaked at $673K in Q4 2025.
  • 200 funds tracked by Wall St. Rank held Immunome as of Q1 2026.

Based on Aquatic Capital Management's 13F filing for Q1 2026, filed 15 May 2026.